Skip to main content
Log in

Advanced glycation endproducts induce self- and cross-tolerance in monocytes

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Introduction

Advanced glycation endproducts (AGEs) are well-known inflammatory mediators, which are recognized by immune cells through their corresponding receptor RAGE and have been shown to participate in the pathophysiology of a variety of acute as well as chronic inflammatory diseases. Nevertheless, no data are available on the aftermath of AGE recognition on immune cells.

Materials and methods

We used the monocytic cell line MonoMac6 as well as primary human monocytes for double stimulation experiments. We measured secreted as well as intracellular levels of TNF-α using ELISA and flow cytometry. In addition, gene expression of surface receptors (RAGE and TLR4) and TNF were measured by qPCR.

Results

Stimulation with AGE leads to a dose-dependent induction of self- and cross-tolerance in both primary monocytes as well as the MonoMac6 cell line. The AGE tolerance depended neither on a decreased expression of RAGE or TLR4, nor on a decrease of TNF-α expression. Nevertheless, intracellular TNF-α was decreased, hinting towards a posttranscriptional regulation.

Conclusion

High levels of AGEs are capable to activate immune cells at first, but induce a secondary state of hypo-responsiveness in these cells. Based on the origin of its causal agent, we propose this phenomenon to be “metabolic tolerance”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–20.

    Article  CAS  PubMed  Google Scholar 

  2. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007;81(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  3. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21(1):11–9.

    Article  CAS  PubMed  Google Scholar 

  4. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108(7):949–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Buckley ST, Ehrhardt C. The receptor for advanced glycation end products (RAGE) and the lung. J Biomed Biotechnol. 2010;2010:917108.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Xie J, Méndez JD, Méndez-Valenzuela V, Aguilar-Hernández MM. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal. 2013;25(11):2185–97.

    Article  CAS  PubMed  Google Scholar 

  7. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44(2):129–46.

    Article  CAS  PubMed  Google Scholar 

  8. de Courten B, de Courten MP, Soldatos G, Dougherty SL, Straznicky N, Schlaich M, et al. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial. Am J Clin Nutr. 2016;103(6):1426–33 (American Society for Nutrition).

    Article  PubMed  Google Scholar 

  9. Beeson PB. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc Soc Exp Biol Med. 1946;61:248–50.

    Article  CAS  PubMed  Google Scholar 

  10. Virca GD, Kim SY, Glaser KB, Ulevitch RJ. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J Biol Chem. 1989;264(36):21951–6.

    CAS  PubMed  Google Scholar 

  11. Uhle F, Lichtenstern C, Brenner T, Fleming T, Koch C, Hecker A, et al. Role of the RAGE Axis during the Immune Response after Severe Trauma: A Prospective Pilot Study. Mediators Inflamm. 2015;2015:691491 (Hindawi Publishing Corporation).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Brenner T. Methylglyoxal as a new biomarker in patients with septic shock: an observational clinical study. Crit Care. 2015;18(6):1–11.

    Google Scholar 

  13. Otto GP, Sossdorf M, Claus RA, Rödel J, Menge K, Reinhart K, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care. 2011;15(4):R183 (BioMed Central Ltd).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M. Immunosuppression following surgical and traumatic injury. Surg Today. 2010;40(9):793–808.

    Article  CAS  PubMed  Google Scholar 

  15. López-Collazo E, del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care. 2013;17(6):242.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock REW. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol. 2011;186(12):7243–54.

    Article  CAS  PubMed  Google Scholar 

  17. Aneja R, Odoms K, Dunsmore K, Shanley TP, Wong HR. Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J Immunol. 2006;177(10):7184–92.

    Article  CAS  PubMed  Google Scholar 

  18. Jacinto R, Hartung T, McCall C, Li L. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol. 2002;168(12):6136–41.

    Article  CAS  PubMed  Google Scholar 

  19. Mizel SB, Snipes JA. Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from toll-like receptor 5. J Biol Chem. 2002;277(25):22414–20.

    Article  CAS  PubMed  Google Scholar 

  20. Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswald-Richter K, et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest. 2006;116(4):916–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Günther J, Vogt N, Hampel K, Bikker R, Page S, Müller B, et al. Identification of two forms of TNF tolerance in human monocytes: differential inhibition of NF-κB/AP-1- and PP1-associated signaling. J Immunol. 2014;192(7):3143–55.

    Article  PubMed  Google Scholar 

  22. Austermann J, Friesenhagen J, Fassl SK, Ortkras T, Burgmann J, Barczyk-Kahlert K, et al. Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep. 2014;9(6):2112–23.

    Article  CAS  PubMed  Google Scholar 

  23. Aneja RK, Tsung A, Sjodin H, Gefter JV, Delude RL, Billiar TR, et al. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. J Leukoc Biol. 2008;84(5):1326–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Lantos J, Földi V, Rőth E, Wéber G, Bogár L, Csontos C. Burn trauma induces early HMGB1 release in patients: its correlation with cytokines. Shock. 2010;33(6):562–7.

    Article  CAS  PubMed  Google Scholar 

  25. Hofer S, Uhle F, Fleming T, Hell C, Schmoch T, Bruckner T, et al. RAGE-mediated inflammation in patients with septic shock. J Surg Res. 2016;202(2):315–27.

    Article  CAS  PubMed  Google Scholar 

  26. Li JF, Schmidt AM. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem. 1997;272(26):16498–506.

    Article  CAS  PubMed  Google Scholar 

  27. El Gazzar M, Yoza BK, Hu JYQ, Cousart SL, McCall CE. Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance. J Biol Chem. 2007;282(37):26857–64.

    Article  PubMed  Google Scholar 

  28. O’Neill L. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11(3):163–75.

    Article  PubMed  Google Scholar 

  29. Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 2013;12(12):1160–5.

    Article  CAS  PubMed  Google Scholar 

  30. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL, et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature. 2011;471(7340):591–6.

    Article  CAS  PubMed  Google Scholar 

  31. Cheng S-C, Scicluna BP, Arts RJW, Gresnigt MS, Lachmandas E, Giamarellos-Bourboulis EJ, et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol. 2016;17(4):406–13.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Author notes

  1. Florian Uhle and Sebastian Weiterer are first authors.

    Authors

    Contributions

    F.U., T.B., C.L., M.A.W.: design and organization of the experiments, performed experiments, data analysis and collection, interpretation of the results and writing of the manuscript. S.W., B.S.: performed sample measurements, interpretation of results and critical revision of the manuscript.

    Corresponding author

    Correspondence to Florian Uhle.

    Ethics declarations

    Conflict of interest

    The authors declare that there is no conflict of interest regarding the publication of this manuscript. The study was not funded.

    Additional information

    Responsible Editor: Artur Bauhofer.

    Electronic supplementary material

    Below is the link to the electronic supplementary material.

    11_2017_1076_MOESM1_ESM.tiff

    Supplementary Fig. 1: Dependency of tolerance induction on glycation and RAGE receptor. (A) MM6 cells were primed for 24 h with unmodified BSA, AGE-modified BSA or LPS for 24 h and re-stimulated with the same compounds for additional 24 h. Supernatant TNF-α was assessed by ELISA and graph shows mean ± SEM, n = 3. (B) MM6 cells were primed (or left unprimed) in the presence of RAGE inhibitor 230 nM FPS-ZM1 for 24 h and re-stimulated with AGE for additional 24 h. Supernatant TNF-α was assessed by ELISA and graph shows mean ± SEM, n = 4. *: p ≤ 0.05. (TIFF 325 kb)

    11_2017_1076_MOESM2_ESM.tif

    Supplementary Fig. 2: Impact of LPS- and AGE-tolerance on the production of different cytokines. MM6 cells were primed with increasing doses of either LPS or AGE for 24 h and subsequently re-stimulated with LPS (left column) or AGE-BSA (right column) for further 24 h. Graph shows mean ± SEM, n = 3. (TIFF 5462 kb)

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Uhle, F., Weiterer, S., Siegler, B.H. et al. Advanced glycation endproducts induce self- and cross-tolerance in monocytes. Inflamm. Res. 66, 961–968 (2017). https://doi.org/10.1007/s00011-017-1076-9

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00011-017-1076-9

    Keywords

    Navigation